A community of 30,000 US Transcriptionist serving Medical Transcription Industry
On the closing date of the merger, in addition to the restricted shares granted to Messrs. Finke, Koll and Fritsch and to encourage other employees of M*Modal to join the Company, the Company granted to 89 employees of M*Modal that became employees of the Company or one of its subsidiaries up to an aggregate of 391,782 restricted shares of the Company's common stock. For each such employee, such employee's restricted shares will vest proportionally over a three-year period based on such employee's continued service, subject to full acceleration upon termination without cause or resignation with good reason. The shares were granted to such employees as "inducement awards" and therefore, consistent with applicable NASDAQ rules, did not reduce the shares reserved for issuance under the Company's stockholder approved equity plans.
http://www.marketwatch.com/story/medquist-holdings-inc-completes-merger-with-mmodal-enabling-value-driven-clinical-information-for-the-healthcare-industry-2011-08-18?reflink=MW_news_stmp